Junshi Biosciences experiments with $414m HK IPO
Shanghai Junshi Biosciences has kicked off bookbuilding for its potential HK$3.24bn ($414.4m) IPO.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts